Semaglutide mimics your body's GLP-1 hormone, boosting insulin secretion and slowing the movement of food through your digestive system
Discontinuing Zepbound typically results in weight regain for most patients, though the extent and timeline vary considerably among individuals
That is different from semaglutide and tirzepatide, where weight loss typically levels off around 60 to 72 weeks
**Must not have allergy to sulfa drugs
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
That is an important question, but it needs careful language